European stocks traded slightly positive Wednesday amid continued hopes for robust economic recovery next year and as AstraZeneca's COVID-19 vaccine received its first approval for emergency supply in the UK amid the massive vaccination drive across Europe.
Meanwhile, investors remain concerned following uncertainty about whether the U.S. Senate would approve a measure increasing the size of the stimulus checks to $2,000.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com